Literature DB >> 7846047

Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen.

D Rognan1, L Scapozza, G Folkers, A Daser.   

Abstract

From the three-dimensional structure of the class I major histocompatibility complex (MHC) HLA-B*2705 protein, several nonnatural peptides were designed either to optimize the interactions of one peptide amino acid (position 3) with its HLA binding pocket (pocket D) or to simplify the T-cell receptor-binding part by substitution with organic spacers. The stability of each MHC-ligand complex was simulated by 150-ps molecular dynamics in a water environment and compared with that of the natural complexes. All peptides were synthesized and tested for binding to the class I MHC protein in an in vitro assembly assay. As predicted from the computed atomic fluctuations and buried surface areas of MHC-bound ligands, bulky hydrophobic side chains at position 3 enhance the binding of a nonameric peptide to the HLA-B27 protein. Furthermore, it was possible to simplify half of the peptide sequence (residues 4-8) by replacement with organic fragments without altering the affinity of the designed ligands for the class I MHC protein. This study constitutes an initial step toward the rational design of nonpeptide class I MHC ligands for use in the selective immunotherapy of autoimmune diseases associated with particular HLA alleles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7846047      PMCID: PMC42698          DOI: 10.1073/pnas.92.3.753

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

2.  Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding.

Authors:  Y Saito; P A Peterson; M Matsumura
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

3.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

Authors:  K C Parker; M A Bednarek; J E Coligan
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

4.  A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis.

Authors:  B A Jameson; J M McDonnell; J C Marini; R Korngold
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

5.  HLA-B27 binding peptides derived from the 57 kD heat shock protein of Chlamydia trachomatis: novel insights into the peptide binding rules.

Authors:  A Daser; H Urlaub; P Henklein
Journal:  Mol Immunol       Date:  1994-04       Impact factor: 4.407

6.  Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28.

Authors:  P Parham; F M Brodsky
Journal:  Hum Immunol       Date:  1981-12       Impact factor: 2.850

Review 7.  Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands.

Authors:  B D Evavold; J Sloan-Lancaster; P M Allen
Journal:  Immunol Today       Date:  1993-12

8.  Recognition of HLA-B27 and related antigen by a monoclonal antibody.

Authors:  S A Ellis; C Taylor; A McMichael
Journal:  Hum Immunol       Date:  1982-08       Impact factor: 2.850

9.  Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

Authors:  G Y Ishioka; L Adorini; J C Guery; F C Gaeta; R LaFond; J Alexander; M F Powell; A Sette; H M Grey
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

10.  Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding.

Authors:  K C Parker; W E Biddison; J E Coligan
Journal:  Biochemistry       Date:  1994-06-21       Impact factor: 3.162

View more
  7 in total

1.  Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two alpha beta T cell receptors.

Authors:  D Rognan; A Stryhn; L Fugger; S Lyngbaek; J Engberg; P S Andersen; S Buus
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  In-solution enrichment identifies peptide inhibitors of protein-protein interactions.

Authors:  Fayçal Touti; Zachary P Gates; Anupam Bandyopadhyay; Guillaume Lautrette; Bradley L Pentelute
Journal:  Nat Chem Biol       Date:  2019-03-18       Impact factor: 15.040

3.  Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.

Authors:  D Rognan; S Krebs; O Kuonen; J R Lamas; J A López de Castro; G Folkers
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

4.  Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.

Authors:  F Boisgérault; V Tieng; M C Stolzenberg; N Dulphy; I Khalil; R Tamouza; D Charron; A Toubert
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

5.  Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules.

Authors:  M Bouvier; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

6.  T-cell epitope prediction and immune complex simulation using molecular dynamics: state of the art and persisting challenges.

Authors:  Matthew N Davies; Darren R Flower; Kanchan Phadwal; Isabel K Macdonald; Peter V Coveney; Shunzhou Wan
Journal:  Immunome Res       Date:  2010-11-03

7.  IntroSpect: Motif-Guided Immunopeptidome Database Building Tool to Improve the Sensitivity of HLA I Binding Peptide Identification by Mass Spectrometry.

Authors:  Le Zhang; Geng Liu; Guixue Hou; Haitao Xiang; Xi Zhang; Ying Huang; Xiuqing Zhang; Bo Li; Leo J Lee
Journal:  Biomolecules       Date:  2022-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.